Adaptationth

05/05/2020

Hello everyone from Adaptationth research lab!

At Adaptationth, we are at the forefront of cannabis delivery and nanotechnology. Everyday we get closer to creating the future of safe and effective cannabis use to treat a wide variety of diseases and issues.

Today, we have an article about the intersection of Cannabis and Nanotech.

Follow for cutting edge industry updates.

Excerpt:

“When you think about cannabis and the businesses that market it, you have to think beyond the traditional image of the rolled-up joint. That consumption method is bad for the lungs, outdated, and inefficient. The future of cannabis consumption is about to go through a huge change thanks to a tiny innovation: nanotechnology.
This new science is helping to create an alternative way for people to take cannabis and get more CBD and THC oil out of a product: It is also inconspicuous, effective, efficient, and clean. Businesses only succeed when they solve a problem and, through nanotechnology, cannabis businesses can provide the benefits of cannabis use in a healthy way that doctors and patients can feel comfortable with. In the simplest terms, nanotechnology allows cannabis consumers to obtain the desired medical benefits from the plant without smoking and sacrificing their health in exchange“
https://www.greenentrepreneur.com/article/338072

Why nanotechnology just might be the future of w**d.

05/01/2020

Hello everyone from the Adaptationth investment team!

At Adaptationth, we watch all industry movement. This helps us determine how best to fund our amazing research, and leverage opportunities where cannabis technology and market demands meet.

Today, we have some investment news and info around transdermal deliveries, a core product in our research lab.

Follow for cutting edge industry updates

Excerpt:

“Today’s common methods for consuming cannabis products — smoking, edibles, v***r, etc. — all suffer from a major drawback in that only a small percentage of the cannabinoids that the consumer puts in their body actually makes it to the cannabinoid receptors in the brain. When using the methods available today, as much as 98 percent of the active compounds can be wasted.

This inefficiency means more than simply a poor value for the consumer. The range of factors that can affect THC and CBD absorption means that it can be difficult to accurately provide a precise dosage. This is one of the major factors holding back the growth of the market for CBD based therapeutics. While CBD is increasingly seen as a safe and effective alternative to more established treatments, health professionals are often wary about the inability to provide accurate dosing.
The solution to this problem is to improve the bioavailability of cannabis-based products by developing new methods for consumption. One way this is being done is through the use of precision technology that allows cannabinoids to pass through the bloodstream uninhibited.”

https://investingnews.com/innspired/transdermal-delivery-technology-medicinal-cannabis-market/

Transdermal delivery technology is critical not only to the consumer, but to the growth of the medicinal cannabis market as a whole.

04/27/2020

Hello everyone from Adaptationth research lab!

At Adaptationth, we are exploring only the best sourcing options for our patients THC and CBD delivery systems.

Today, we have an article from the esteemed scientific journal, Nature.

Follow for cutting edge industry updates.
Excerpt:
“Cannabis is the only plant known to produce tetrahydrocannabinol (THC), but it remains an imperfect vessel for producing the chemical on an industrial scale. The psychoactive substance is normally found only in small outgrowths from the plant known as trichomes, which means that its stalk, stems and leaves are wasted biomass.
Genetic engineering could provide more efficient alternatives. Some researchers and biotechnology companies are aspiring to replace cannabis plants with microorganisms that have been genetically enhanced to spit out THC, the non–psychoactive compound cannabidiol (CBD) and myriad other cannabinoids of pharmaceutical interest. Others are aiming to modify chemical synthesis in the cannabis plant by genetically altering its cells to make the desired molecules from shoot to tip, thereby boosting yield.”

https://www.nature.com/articles/d41586-019-02525-4

Genetic modification could enable industrial-scale production of cannabinoids that have pharmaceutical potential.

04/22/2020

Hello everyone from Adaptationth research lab!

At Adaptationth, we are at the forefront of cannabis delivery and nanotechnology. Everyday we get closer to creating the future of safe and effective cannabis use to treat a wide variety of diseases and issues.

Today, we have an article about the intersection of Cannabis and Nanotech.

Follow for cutting edge industry updates.

Excerpt:

“When you think about cannabis and the businesses that market it, you have to think beyond the traditional image of the rolled-up joint. That consumption method is bad for the lungs, outdated, and inefficient. The future of cannabis consumption is about to go through a huge change thanks to a tiny innovation: nanotechnology.
This new science is helping to create an alternative way for people to take cannabis and get more CBD and THC oil out of a product: It is also inconspicuous, effective, efficient, and clean. Businesses only succeed when they solve a problem and, through nanotechnology, cannabis businesses can provide the benefits of cannabis use in a healthy way that doctors and patients can feel comfortable with. In the simplest terms, nanotechnology allows cannabis consumers to obtain the desired medical benefits from the plant without smoking and sacrificing their health in exchange“

https://www.greenentrepreneur.com/article/338072

04/22/2020

At Adaptationth, we are pushing the boundaries of what can be done in the medical cannabis Industry. In doing so, we stay up to date on research and news, and will be sharing some of this here with you!

Today, we have an article from the National Institute of Health.

Follow Adaptationth for all your cutting edge cannabis news and research.

Excerpt:
“There is a growing body of evidence to suggest that cannabinoids are beneficial for a range of clinical conditions, including pain, inflammation, epilepsy, sleep disorders, the symptoms of multiple sclerosis, anorexia, schizophrenia and other conditions. The transformation of cannabinoids from herbal preparations into highly regulated prescription drugs is therefore progressing rapidly. The development of such drugs requires well-controlled clinical trials to be carried out in order to objectively establish therapeutic efficacy, dose ranges and safety. The low oral bioavailability of cannabinoids has led to feasible methods of administration, such as the transdermal route, intranasal administration and transmucosal adsorption, being proposed. The highly lipophilic nature of cannabinoids means that they are seen as suitable candidates for advanced nanosized drug delivery systems, which can be applied via a range of routes. Nanotechnology-based drug delivery strategies have flourished in several therapeutic fields in recent years and numerous drugs have reached the market. This review explores the most recent developments, from preclinical to advanced clinical trials, in the cannabinoid delivery field, and focuses particularly on pain and inflammation treatment. Likely future directions are also considered and reported.”

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222489/

There is a growing body of evidence to suggest that cannabinoids are beneficial for a range of clinical conditions, including pain, inflammation, epilepsy, sleep disorders, the symptoms of multiple sclerosis, anorexia, schizophrenia and other conditions. ...

01/06/2020